Beyond taxanes: the next generation of microtubule-targeting agents

by Cortes, Javier, Vidal, Maria
Published 2011

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer

by André, Fabrice, Cortés, Javier
Published 2015

Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?

by Pérez-García, José, Cortés, Javier
Published 2012

The ADHD Concomitant Difficulties Scale (ADHD-CDS), a Brief Scale to Measure Comorbidity Associated to ADHD

by Fenollar-Cortés, Javier, Fuentes, Luis J.
Published 2016

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

by Muñoz-Couselo, Eva, Pérez-García, José, Cortés, Javier
Published 2011

Bone metastases: Causes, consequences and therapeutic opportunities

by Perez-Garcia, Jose, Muñoz-Couselo, Eva, Cortes, Javier
Published 2013

Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries

by Monsonego, Joseph, Cortes, Javier, da Silva, Daniel Pereira, Jorge, Anna Francisca, Klein, Patrick
Published 2011

Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

by Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad
Published 2015

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

by Twelves, Chris, Cortes, Javier, Vahdat, Linda, Olivo, Martin, He, Yi, Kaufman, Peter A., Awada, Ahmad
Published 2014

Advanced Extramammary Paget’s Disease of the Groin, Penis, and Scrotum

by Isrow, Derek, Oregel, Karlos Z, Cortes, Javier, Gomez, Henry, Milikowski, Clara, Feun, Lynn, Silva, Orlando
Published 2014

Methane production by treating vinasses from hydrous ethanol using a modified UASB reactor

by España-Gamboa, Elda I, Mijangos-Cortés, Javier O, Hernández-Zárate, Galdy, Maldonado, Jorge A Domínguez, Alzate-Gaviria, Liliana M
Published 2012

Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer

by Prat, Aleix, Carey, Lisa A., Adamo, Barbara, Vidal, Maria, Tabernero, Josep, Cortés, Javier, Parker, Joel S., Perou, Charles M., Baselga, José
Published 2014

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer

by Twelves, Chris, Awada, Ahmad, Cortes, Javier, Yelle, Louise, Velikova, Galina, Olivo, Martin S., Song, James, Dutcus, Corina E., Kaufman, Peter A.
Published 2016

Lkb1 Loss Promotes Tumor Progression of BRAFV600E-Induced Lung Adenomas

by González-Sánchez, Elena, Martín-Caballero, Juan, Flores, Juana María, Hernández-Losa, Javier, Cortés, Javier, Mares, Roso, Barbacid, Mariano, Recio, Juan A.
Published 2013

Exposure–response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters

by Garg, Amit, Li, Jing, Clark, Emma, Knott, Adam, Carrothers, Timothy J., Marier, Jean-François, Cortés, Javier, Brewster, Michael, Visich, Jennifer, Lum, Bert
Published 2013

Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracyclin...

by Kaufman, Peter A., Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A., Velikova, Galina, Olivo, Martin S., He, Yi, Dutcus, Corina E., Cortes, Javier
Published 2015

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve,...

by Miller, Kathy, Cortes, Javier, Hurvitz, Sara A., Krop, Ian E., Tripathy, Debu, Verma, Sunil, Riahi, Kaveh, Reynolds, Joseph G., Wickham, Thomas J., Molnar, Istvan, Yardley, Denise A.
Published 2016

Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway

by Pérez-Alea, Mileidys, Vivancos, Ana, Caratú, Ginevra, Matito, Judit, Ferrer, Berta, Hernandez-Losa, Javier, Cortés, Javier, Muñoz, Eva, Garcia-Patos, Vicente, Recio, Juan A.
Published 2016

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 tria...

by Cortes, Javier, Hudgens, Stacie, Twelves, Chris, Perez, Edith A., Awada, Ahmad, Yelle, Louise, McCutcheon, Susan, Kaufman, Peter A., Forsythe, Anna, Velikova, Galina
Published 2015

“New” metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapy

by Twelves, Christopher, Cortes, Javier, Kaufman, Peter A., Yelle, Louise, Awada, Ahmad, Binder, Terri A., Olivo, Martin, Song, James, O’Shaughnessy, Joyce A., Jove, Maria, Perez, Edith A.
Published 2015